Clinical Trial Update: Iron in Patients With Cardiovascular Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial for iron treatment in cardiovascular disease patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia Iron-deficiency
• Atrial Fibrillation
• Cardiovascular Diseases
• Myocardial Infarction
• Systolic Heart Failure

Snippet

Sponsor: Dr. med. Mahir Karakas | Conditions: Cardiovascular Diseases, Anemia, Iron-deficiency | Phase 3 | Status: TERMINATED